Drug maker tracks Real-World safety of anemia treatment
NCT ID NCT04899661
Summary
This study is monitoring the long-term safety and effectiveness of molidustat, a medication for anemia caused by kidney disease. Researchers are following over 1,000 Japanese patients for up to two years to see how well the drug works in real-world use and to track potential side effects. The study collects health information from regular medical check-ups to understand the drug's safety profile better.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL ANEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Many facilities
Multiple Locations, Japan
Conditions
Explore the condition pages connected to this study.